Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A method for the combined treatment of the decompensations in the patients with the organic personality disorder and the aggressiveness provides for the use of the psychotropic agents, including Risset, and the electric sleep. Within the second week of the treatment, the oral daily dose of Risset is increased from 1.0 mg to 8.0-10.0 mg. In 2 h after the morning dose, the electric sleep is induced by orbital-retroaural variant with the current increase from 15 to 20 mA, pulse rate increase from 5 to 120 Hz, pulse duration increase from 0.2 to 0.5 ms, with increasing the duration of the session from 20 to 75 minutes, with 14 daily procedures in whole.
UAU200805815U2008-05-052008-05-05Method for combined treatment of decompensations in patients with organic personality disorder and aggressiveness
UA35612U
(en)